Roles of Antiviral Therapy in Chronic Hepatitis C Patients Should be Different According to the Stages of Liver Disease Progression

作者: Yasushi Shiratori

DOI: 10.1007/978-4-431-53977-3_21

关键词:

摘要: With an accumulated evidence of natural course patients with hepatitis C virus (HCV) infection, HCV infected died from liver-related disease such as liver cirrhosis/liver failure, or hepatocellular carcinoma. Based on these findings, beneficial effect antiviral therapy for is linked to inhibition HCC development. Because the difference progression speed and fibrotic stage may affect risk development efficacy depends load, genotype host factors (age, gender, stage), benefit differ according step infection. In spite improvement treatment efficacy, still unsatisfactory, but recent studies revealed that retardation could be observed after therapy. Thus, should performed standpoint

参考文章(17)
Yasushi Shiratori, Ryo Nakata, Noboru Shimizu, Hiromasa Katada, Shigemasa Hisamitsu, Eiichi Yasuda, Masayuki Matsumura, Tohru Narita, Kazuhide Kawada, Masao Omata, High Viral Eradication with a Daily 12-Week Natural Interferon-β Treatment Regimen in Chronic Hepatitis C Patients with Low Viral Load Digestive Diseases and Sciences. ,vol. 45, pp. 2414- 2421 ,(2000) , 10.1023/A:1005655428563
Yasushi Shiratori, Naoya Kato, Haruhiko Yoshida, Fumio Imazeki, Ken’ichi Okano, Osamu Yokosuka, Masao Omata, How soon can a virological sustained response be determined after withdrawal of interferon therapy in chronic hepatitis C Journal of Gastroenterology and Hepatology. ,vol. 14, pp. 79- 84 ,(1999) , 10.1046/J.1440-1746.1999.01802.X
Yasushi Shiratori, Mistuhiko Moriyama, Fumio Imazeki, Hitoshi Ohkubo, Naohide Tanaka, Yasuyuki Arakawa, Haruhiko Yoshida, Osamu Yokosuka, Akitaka Shibuya, Kohei Matsuzaki, Etsuko Hashimoto, Naoaki Hayashi, Keiichi Hirata, Yasuo Ohashi, Masao Omata, , A prospective study of interferon therapy modified by pre‐treatment viral load in cirrhotic patients Liver. ,vol. 20, pp. 271- 280 ,(2000) , 10.1034/J.1600-0676.2000.020004271.X
Yasushi Shiratori, Shuichiro Shiina, Takuma Teratani, Masatoshi Imamura, Shun'taro Obi, Shin'pei Sato, Yukihiro Koike, Haruhiko Yoshida, Masao Omata, Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus. Annals of Internal Medicine. ,vol. 138, pp. 299- 306 ,(2003) , 10.7326/0003-4819-138-4-200302180-00008
Masao Omata, Yasushi Shiratori, Long-term effects of interferon therapy on histology and development of hepatocellular carcinoma in hepatitis C. Journal of Gastroenterology and Hepatology. ,vol. 15, ,(2000) , 10.1046/J.1440-1746.2000.02115.X
Yukihiro Koike, Yasushi Shiratori, Shinpei Sato, Shuntaro Obi, Takuma Teratani, Masatoshi Imamura, Keisuke Hamamura, Yasuo Imai, Haruhiko Yoshida, Shuichiro Shiina, Masao Omata, Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus-an analysis of 236 consecutive patients with a single lesion. Hepatology. ,vol. 32, pp. 1216- 1223 ,(2000) , 10.1053/JHEP.2000.20237
Y Shiratori, N Kato, O Yokosuka, F Imazeki, E Hashimoto, N Hayashi, A Nakamura, M Asada, H Kuroda, N Tanaka, Y Arakawa, M Omata, Predictors of the efficacy of interferon therapy in chronic hepatitis C virus infection. Tokyo-Chiba Hepatitis Research Group Gastroenterology. ,vol. 113, pp. 558- 566 ,(1997) , 10.1053/GAST.1997.V113.PM9247476
Haruhiko Yoshida, Yasuyuki Arakawa, Michio Sata, Shuhei Nishiguchi, Michitami Yano, Shigetoshi Fujiyama, Gotarou Yamada, Osamu Yokosuka, Yasushi Shiratori, Masao Omata, Interferon therapy prolonged life expectancy among chronic hepatitis C patients. Gastroenterology. ,vol. 123, pp. 483- 491 ,(2002) , 10.1053/GAST.2002.34785
Yasushi Shiratori, Haruhiko Yoshida, Masao Omata, Management of hepatocellular carcinoma: advances in diagnosis, treatment and prevention Expert Review of Anticancer Therapy. ,vol. 1, pp. 277- 290 ,(2001) , 10.1586/14737140.1.2.277